2023 Q4 Form 10-K Financial Statement
#000164033423002189 Filed on November 16, 2023
Income Statement
Concept | 2023 Q4 | 2023 Q3 | 2023 |
---|---|---|---|
Revenue | $25.00K | $25.00K | $100.0K |
YoY Change | 0.0% | 0.0% | 140.01% |
Cost Of Revenue | $22.90K | $22.86K | $94.63K |
YoY Change | 0.03% | -40.17% | 147.63% |
Gross Profit | $2.010K | $2.140K | $5.372K |
YoY Change | -4.6% | -116.2% | 55.62% |
Gross Profit Margin | 8.04% | 8.56% | 5.37% |
Selling, General & Admin | $64.91K | $7.100M | $7.126M |
YoY Change | 1080.18% | 143331.52% | 19722.11% |
% of Gross Profit | 3229.35% | 331769.16% | 132651.71% |
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | |||
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | $64.91K | $7.100M | $7.124M |
YoY Change | 1081.27% | -78987.33% | 19714.35% |
Operating Profit | -$62.90K | -$7.098M | -$7.121M |
YoY Change | 1756.58% | 168491.92% | 21808.44% |
Interest Expense | $919.00 | -$1.150K | $3.990K |
YoY Change | 10.32% | 91.67% | 158.75% |
% of Operating Profit | |||
Other Income/Expense, Net | -$91.00 | -$3.977K | |
YoY Change | -110.92% | -357.91% | |
Pretax Income | -$62.99K | -$7.099M | -$7.125M |
YoY Change | 1392.35% | 147485.45% | 20827.79% |
Income Tax | $0.00 | $0.00 | $0.00 |
% Of Pretax Income | |||
Net Earnings | -$62.99K | -$7.099M | -$7.125M |
YoY Change | 1392.35% | 147485.45% | 20827.79% |
Net Earnings / Revenue | -251.97% | -28395.44% | -7124.59% |
Basic Earnings Per Share | |||
Diluted Earnings Per Share | $0.00 | -$0.21 | -$0.20 |
COMMON SHARES | |||
Basic Shares Outstanding | 35.41M shares | ||
Diluted Shares Outstanding | 35.54M shares |
Balance Sheet
Concept | 2023 Q4 | 2023 Q3 | 2023 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $37.44K | $118.6K | $118.6K |
YoY Change | 1160.61% | 3737.22% | 3737.22% |
Cash & Equivalents | $37.44K | $118.6K | |
Short-Term Investments | |||
Other Short-Term Assets | $0.00 | $2.700K | $2.700K |
YoY Change | -100.0% | 4400.0% | 4400.0% |
Inventory | |||
Prepaid Expenses | $0.00 | ||
Receivables | $8.333K | $8.333K | $8.330K |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $45.78K | $129.6K | $129.6K |
YoY Change | 256.16% | 930.88% | 931.03% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | |||
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | $0.00 | $0.00 | $0.00 |
YoY Change | |||
TOTAL ASSETS | |||
Total Short-Term Assets | $45.78K | $129.6K | $129.6K |
Total Long-Term Assets | $0.00 | $0.00 | $0.00 |
Total Assets | $45.78K | $129.6K | $129.6K |
YoY Change | 256.16% | 930.88% | 931.03% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $29.74K | $32.39K | $32.39K |
YoY Change | 62.68% | 90.12% | 90.19% |
Accrued Expenses | $0.00 | $0.00 | |
YoY Change | -100.0% | -100.0% | |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $28.40K | $47.50K | $47.50K |
YoY Change | -25.16% | 39.91% | 39.91% |
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $58.13K | $79.88K | $79.88K |
YoY Change | -8.96% | 32.73% | 32.71% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $58.13K | $79.88K | $79.88K |
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
Total Liabilities | $58.13K | $79.88K | $79.88K |
YoY Change | -8.96% | 32.73% | 32.71% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$7.586M | -$7.523M | |
YoY Change | 1785.76% | 1789.94% | |
Common Stock | $4.141K | $4.141K | |
YoY Change | 5.61% | -98.82% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | $600.00 | ||
YoY Change | 0.0% | ||
Treasury Stock Shares | |||
Shareholders Equity | -$12.36K | $49.72K | $49.72K |
YoY Change | |||
Total Liabilities & Shareholders Equity | $45.78K | $129.6K | $129.6K |
YoY Change | 256.16% | 930.88% | 931.03% |
Cashflow Statement
Concept | 2023 Q4 | 2023 Q3 | 2023 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$62.99K | -$7.099M | -$7.125M |
YoY Change | 1392.35% | 147485.45% | 20827.79% |
Depreciation, Depletion And Amortization | |||
YoY Change | |||
Cash From Operating Activities | -$62.02K | -$88.07K | -$98.07K |
YoY Change | 1405.41% | 1346.14% | 235.16% |
INVESTING ACTIVITIES | |||
Capital Expenditures | |||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | |||
YoY Change | |||
Cash From Investing Activities | $0.00 | ||
YoY Change | |||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | $200.0K | ||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | -$19.10K | 203.5K | $213.6K |
YoY Change | -577.55% | 3971.0% | 560.38% |
NET CHANGE | |||
Cash From Operating Activities | -$62.02K | -88.07K | -$98.07K |
Cash From Investing Activities | $0.00 | ||
Cash From Financing Activities | -$19.10K | 203.5K | $213.6K |
Net Change In Cash | -$81.13K | 115.5K | $115.5K |
YoY Change | 67504.17% | -10694.5% | 3653.07% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$62.02K | -$88.07K | -$98.07K |
Capital Expenditures | |||
Free Cash Flow | |||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2022Q3 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
83588 | usd |
CY2022Q3 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | usd |
CY2022Q3 | pnht |
Effective Tax Rate
EffectiveTaxRate
|
0.21 | pure |
CY2022Q3 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
83588 | usd |
CY2023Q3 | us-gaap |
Preferred Stock Discount On Shares
PreferredStockDiscountOnShares
|
50000000 | usd |
CY2023Q3 | us-gaap |
Preferred Stock No Par Value
PreferredStockNoParValue
|
0.0001 | |
CY2023Q3 | pnht |
Common Stock Shares Authorized1
CommonStockSharesAuthorized1
|
550000000 | shares |
CY2023Q3 | pnht |
Common Stock Par Value
CommonStockParValue
|
0.0001 | |
CY2022 | pnht |
Fixed Monthly Payment
FixedMonthlyPayment
|
8333 | usd |
CY2022 | us-gaap |
Revenues
Revenues
|
41666 | usd |
CY2023 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001620749 | |
CY2023 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2023 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--07-31 | |
CY2023 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2023 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2023 | |
CY2023 | dei |
Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
|
false | |
CY2023 | dei |
Entity File Number
EntityFileNumber
|
000-55569 | |
CY2022Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
50000000 | shares |
CY2022Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q3 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2022Q3 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2023Q3 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2022Q3 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2022Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
550000000 | shares |
CY2022Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
41410000 | shares |
CY2022Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
39210000 | shares |
CY2022Q3 | us-gaap |
Preferred Stock Discount On Shares
PreferredStockDiscountOnShares
|
50000000 | usd |
CY2022Q3 | us-gaap |
Preferred Stock No Par Value
PreferredStockNoParValue
|
0.0001 | |
CY2022Q3 | pnht |
Common Stock Par Value
CommonStockParValue
|
0.0001 | |
CY2022Q3 | pnht |
Common Stock Shares Authorized1
CommonStockSharesAuthorized1
|
550000000 | shares |
CY2022Q3 | us-gaap |
Common Unit Outstanding
CommonUnitOutstanding
|
39210000 | shares |
CY2023Q3 | pnht |
Restricted Common Stock Value
RestrictedCommonStockValue
|
6600200 | usd |
CY2023 | dei |
Document Type
DocumentType
|
10-K | |
CY2023 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
CY2023 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-07-31 | |
CY2023 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2023 | dei |
Entity Registrant Name
EntityRegistrantName
|
PANAMERA HOLDINGS CORPORATION | |
CY2023 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
NV | |
CY2023 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
46-5707326 | |
CY2023 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
5051 Westheimer, Suite 1200 | |
CY2023 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Houston | |
CY2023 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
TX | |
CY2023 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
77056 | |
CY2023 | dei |
City Area Code
CityAreaCode
|
713 | |
CY2023 | dei |
Local Phone Number
LocalPhoneNumber
|
878-7200 | |
CY2023 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2023 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2023 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2023 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2023 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2023 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2023 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2023 | dei |
Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
|
false | |
CY2023 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2022Q1 | dei |
Entity Public Float
EntityPublicFloat
|
12487500 | usd |
CY2023Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
35410000 | shares |
CY2023 | dei |
Auditor Firm
AuditorFirmId
|
2738 | |
CY2023 | dei |
Auditor Name
AuditorName
|
M&K CPAS, PLLC | |
CY2023 | dei |
Auditor Location
AuditorLocation
|
The Woodlands, TX | |
CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
118569 | usd |
CY2022Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
3087 | usd |
CY2023Q3 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
0 | usd |
CY2022Q3 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
55 | usd |
CY2023Q3 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
8333 | usd |
CY2022Q3 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
8332 | usd |
CY2023Q3 | pnht |
Other Receivable Related Party
OtherReceivableRelatedParty
|
0 | usd |
CY2022Q3 | pnht |
Other Receivable Related Party
OtherReceivableRelatedParty
|
1098 | usd |
CY2023Q3 | pnht |
Employee Advanced Current
EmployeeAdvancedCurrent
|
2700 | usd |
CY2022Q3 | pnht |
Employee Advanced Current
EmployeeAdvancedCurrent
|
0 | usd |
CY2023Q3 | us-gaap |
Assets Current
AssetsCurrent
|
129602 | usd |
CY2022Q3 | us-gaap |
Assets Current
AssetsCurrent
|
12572 | usd |
CY2023Q3 | us-gaap |
Assets
Assets
|
129602 | usd |
CY2022Q3 | us-gaap |
Assets
Assets
|
12572 | usd |
CY2023Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
32385 | usd |
CY2022Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
17034 | usd |
CY2023Q3 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
0 | usd |
CY2022Q3 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
7706 | usd |
CY2023Q3 | us-gaap |
Deferred Revenue And Credits Current
DeferredRevenueAndCreditsCurrent
|
0 | usd |
CY2022Q3 | us-gaap |
Deferred Revenue And Credits Current
DeferredRevenueAndCreditsCurrent
|
1500 | usd |
CY2023Q3 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
47499 | usd |
CY2022Q3 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
33946 | usd |
CY2023Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
79884 | usd |
CY2022Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
60186 | usd |
CY2023Q3 | us-gaap |
Liabilities
Liabilities
|
79884 | usd |
CY2022Q3 | us-gaap |
Liabilities
Liabilities
|
60186 | usd |
CY2023Q3 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | usd |
CY2022Q3 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | usd |
CY2022Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
39210000 | shares |
CY2023Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
4141 | usd |
CY2022Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
3921 | usd |
CY2023Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
7570875 | usd |
CY2022Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
346505 | usd |
CY2023Q3 | pnht |
Common Stock Subscriptions Receivable On Related Parties Current
CommonStockSubscriptionsReceivableOnRelatedPartiesCurrent
|
-2000 | usd |
CY2022Q3 | pnht |
Common Stock Subscriptions Receivable On Related Parties Current
CommonStockSubscriptionsReceivableOnRelatedPartiesCurrent
|
0 | usd |
CY2022Q3 | us-gaap |
Treasury Stock Common Shares
TreasuryStockCommonShares
|
0 | shares |
CY2023Q3 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
600 | usd |
CY2022Q3 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
0 | usd |
CY2023Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-7522698 | usd |
CY2022Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-398040 | usd |
CY2023Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
49718 | usd |
CY2022Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-47614 | usd |
CY2023Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
129602 | usd |
CY2022Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
12572 | usd |
CY2023 | pnht |
Revenues Related Party
RevenuesRelatedParty
|
100001 | usd |
CY2022 | pnht |
Revenues Related Party
RevenuesRelatedParty
|
41666 | usd |
CY2023 | us-gaap |
Costs And Expenses Related Party
CostsAndExpensesRelatedParty
|
94629 | usd |
CY2022 | us-gaap |
Costs And Expenses Related Party
CostsAndExpensesRelatedParty
|
38214 | usd |
CY2023 | us-gaap |
Gross Profit
GrossProfit
|
5372 | usd |
CY2022 | us-gaap |
Gross Profit
GrossProfit
|
3452 | usd |
CY2023 | us-gaap |
Professional Fees
ProfessionalFees
|
60337 | usd |
CY2022 | us-gaap |
Professional Fees
ProfessionalFees
|
22953 | usd |
CY2023 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
7065716 | usd |
CY2022 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
13001 | usd |
CY2023 | us-gaap |
Operating Expenses
OperatingExpenses
|
7124053 | usd |
CY2022 | us-gaap |
Operating Expenses
OperatingExpenses
|
35954 | usd |
CY2023 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-7120681 | usd |
CY2022 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-32502 | usd |
CY2023 | us-gaap |
Interest Income Other
InterestIncomeOther
|
13 | usd |
CY2022 | us-gaap |
Interest Income Other
InterestIncomeOther
|
0 | usd |
CY2023 | us-gaap |
Interest Expense
InterestExpense
|
3990 | usd |
CY2022 | us-gaap |
Interest Expense
InterestExpense
|
1542 | usd |
CY2023 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-3977 | usd |
CY2022 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-1542 | usd |
CY2023 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
-7124658 | usd |
CY2022 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
-34044 | usd |
CY2023 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | usd |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | usd |
CY2023 | pnht |
Earnings Per Share Basic And Diluted Common Stock
EarningsPerShareBasicAndDilutedCommonStock
|
-0.20 | |
CY2022 | pnht |
Earnings Per Share Basic And Diluted Common Stock
EarningsPerShareBasicAndDilutedCommonStock
|
-0.00 | |
CY2023 | pnht |
Weighted Average Number Of Basic And Diluted Shares Outstanding
WeightedAverageNumberOfBasicAndDilutedSharesOutstanding
|
35535137 | shares |
CY2022 | pnht |
Weighted Average Number Of Basic And Diluted Shares Outstanding
WeightedAverageNumberOfBasicAndDilutedSharesOutstanding
|
39210000 | shares |
CY2021Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-15112 | usd |
CY2022 | pnht |
Imputed Interest On Related Party Loan
ImputedInterestOnRelatedPartyLoan
|
1542 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-34044 | usd |
CY2022Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-47614 | usd |
CY2023 | pnht |
Cash Received From Issuance Of Common Stock
CashReceivedFromIssuanceOfCommonStock
|
7218000 | usd |
CY2023 | pnht |
Imputed Interest On Related Party Loan
ImputedInterestOnRelatedPartyLoan
|
3990 | usd |
CY2023 | pnht |
Share Surrender Held As Treasury Stock Amount
ShareSurrenderHeldAsTreasuryStockAmount
|
0 | usd |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-7124658 | usd |
CY2023Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
49718 | usd |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-7124658 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-34044 | usd |
CY2023 | pnht |
Imputed Interest On Related Party Loan
ImputedInterestOnRelatedPartyLoan
|
3990 | usd |
CY2022 | pnht |
Imputed Interest On Related Party Loan
ImputedInterestOnRelatedPartyLoan
|
1542 | usd |
CY2023 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
7018000 | usd |
CY2022 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
0 | usd |
CY2023 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
15351 | usd |
CY2022 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
3520 | usd |
CY2023 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-1 | usd |
CY2022 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-8332 | usd |
CY2023 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
55 | usd |
CY2022 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-55 | usd |
CY2023 | us-gaap |
Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
|
1098 | usd |
CY2022 | us-gaap |
Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
|
-1098 | usd |
CY2023 | us-gaap |
Increase Decrease In Deferred Revenue And Customer Advances And Deposits
IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits
|
-1500 | usd |
CY2022 | us-gaap |
Increase Decrease In Deferred Revenue And Customer Advances And Deposits
IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits
|
1500 | usd |
CY2023 | pnht |
Increasedecreaseinpayroll Liabilities Related Party
IncreasedecreaseinpayrollLiabilitiesRelatedParty
|
-7706 | usd |
CY2022 | pnht |
Increasedecreaseinpayroll Liabilities Related Party
IncreasedecreaseinpayrollLiabilitiesRelatedParty
|
7706 | usd |
CY2023 | pnht |
Increase Decrease In Employeeadvanced
IncreaseDecreaseInEmployeeadvanced
|
-2700 | usd |
CY2022 | pnht |
Increase Decrease In Employeeadvanced
IncreaseDecreaseInEmployeeadvanced
|
0 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-98071 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-29261 | usd |
CY2023 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
13553 | usd |
CY2022 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
32338 | usd |
CY2023 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
200000 | usd |
CY2022 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
213553 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
32338 | usd |
CY2023 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
115482 | usd |
CY2022 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
3077 | usd |
CY2022Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
3087 | usd |
CY2021Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
10 | usd |
CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
118569 | usd |
CY2022Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
3087 | usd |
CY2023 | us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | usd |
CY2022 | us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | usd |
CY2023 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | usd |
CY2022 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | usd |
CY2023 | pnht |
Share Surrender Held As Treasury Stock
ShareSurrenderHeldAsTreasuryStock
|
600 | usd |
CY2022 | pnht |
Share Surrender Held As Treasury Stock
ShareSurrenderHeldAsTreasuryStock
|
0 | usd |
CY2023 | pnht |
Common Stock Subscription Receivable For Common Stock Issued To Related Parties
CommonStockSubscriptionReceivableForCommonStockIssuedToRelatedParties
|
2000 | usd |
CY2022 | pnht |
Common Stock Subscription Receivable For Common Stock Issued To Related Parties
CommonStockSubscriptionReceivableForCommonStockIssuedToRelatedParties
|
0 | usd |
CY2023 | pnht |
Organization Description Of Business And Going Concern
OrganizationDescriptionOfBusinessAndGoingConcern
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong>NOTE 1 –</strong> <strong>ORGANIZATION, DESCRIPTION OF BUSINESS AND GOING CONCERN</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Panamera Holdings Corporation (the “Company”) is a Nevada corporation incorporated on May 20, 2014. It is based in Houston, TX. Effective October 21, 2021, the Company changed its name from Panamera Healthcare Corporation to Panamera Holdings Corporation and increased the number of authorized shares of common stock from 150,000,000 shares of common stock to 550,000,000 shares of common stock, par value $0.0001 per share. The Company’s fiscal year end is July 31.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company intended to offer management and consulting services to healthcare organizations but has redirected its efforts to now pursuing business opportunities, including but not limited to the environmental services industry, emerging innovative technologies and individual health choices led by innovation with integration. To date, the Company’s activities have been limited to its formation and the raising of equity capital and consulting services related to an agreement effective on March 1, 2022, with First DP Ventures, LP dba First Primary Care of Houston, Texas.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On June 2, 2023, The Company’s Board of Directors approved the creation of three wholly-owned subsidiaries, named Panamera Metals Corporation, Panamera Technologies Corporation and Panamera Waste Corporation. On July 20, 2023, the three wholly-owned subsidiaries were registered in the State of Texas. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><strong><em>Going Concern</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and the liquidation of liabilities in the normal course of business. As of July 31, 2023, the Company has suffered recurring losses from operations, has an accumulated deficit of $7,522,698 and earned limited revenues of $100,001 during the year ended July 31, 2023. The Company intends to fund operations through equity financing arrangements and related party advances, which may be insufficient to fund its capital expenditures, working capital and other cash requirements for the year ending July 31, 2024.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The ability of the Company to emerge from an early stage is dependent upon, among other things, obtaining additional financing to continue operations, and development of its business plan. In response to these problems, management intends to raise additional funds through public or private placement offerings.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p> | |
CY2023 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The Company’s consolidated financial instruments that are exposed to concentrations of credit risk primarily consist of its cash and cash equivalents and related party payables that it will likely incur in the near future. The Company places its cash and cash equivalents with financial institutions of high credit worthiness. At times, its cash and cash equivalents with a particular financial institution may exceed any applicable government insurance limits. The Company’s management plans to assess the financial strength and credit worthiness of any parties to which it extends funds, and as such, it believes that any associated credit risk exposures are limited.</p> | |
CY2023 | pnht |
Fixed Monthly Payment
FixedMonthlyPayment
|
8333 | usd |
CY2023Q3 | us-gaap |
Customer Deposits Current
CustomerDepositsCurrent
|
0 | usd |
CY2022Q3 | us-gaap |
Customer Deposits Current
CustomerDepositsCurrent
|
1500 | usd |
CY2023 | pnht |
Shareholder Financed For Operation Expense
ShareholderFinancedForOperationExpense
|
13553 | usd |
CY2022 | pnht |
Shareholder Financed For Operation Expense
ShareholderFinancedForOperationExpense
|
32338 | usd |
CY2023Q3 | pnht |
Loan To Related Parties
LoanToRelatedParties
|
47499 | usd |
CY2022Q3 | pnht |
Loan To Related Parties
LoanToRelatedParties
|
33946 | usd |
CY2023 | pnht |
Interest On Related Party Loans
InterestOnRelatedPartyLoans
|
3990 | usd |
CY2022 | pnht |
Interest On Related Party Loans
InterestOnRelatedPartyLoans
|
1542 | usd |
CY2023 | us-gaap |
Salaries And Wages
SalariesAndWages
|
2800 | usd |
CY2022 | us-gaap |
Salaries And Wages
SalariesAndWages
|
0 | usd |
CY2023 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | pure |
CY2023Q3 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
7522698 | usd |
CY2022Q3 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
398040 | usd |
CY2023Q3 | pnht |
Effective Tax Rate
EffectiveTaxRate
|
0.21 | pure |
CY2023Q3 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
1579767 | usd |
CY2023Q3 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
1579767 | usd |
CY2023Q3 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | usd |
CY2023Q2 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
7522698 | usd |
CY2023 | pnht |
Expiry Period Description
ExpiryPeriodDescription
|
which begin to expire between 2038 and 2042 | |
CY2023 | pnht |
Ownership Changes In Operating Loss Carry Forward
OwnershipChangesInOperatingLossCarryForward
|
0.50 | pure |
CY2022Q4 | pnht |
Common Stock Surrender Shares
CommonStockSurrenderShares
|
6000000 | shares |
CY2023Q3 | pnht |
Restrictedcommon Stock Share Issued
RestrictedcommonStockShareIssued
|
2000000 | shares |
CY2023 | us-gaap |
Increase Decrease Due From Other Related Parties
IncreaseDecreaseDueFromOtherRelatedParties
|
2000 | usd |
CY2022Q3 | us-gaap |
Common Unit Issued
CommonUnitIssued
|
39210000 | shares |
CY2023Q3 | us-gaap |
Common Unit Issued
CommonUnitIssued
|
41410000 | shares |
CY2023Q3 | us-gaap |
Common Unit Outstanding
CommonUnitOutstanding
|
35410000 | shares |
CY2023Q3 | pnht |
Treasury Common Stock Shares
TreasuryCommonStockShares
|
6000000 | shares |
CY2023Q3 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
600 | usd |
CY2023 | us-gaap |
Revenues
Revenues
|
100001 | usd |
CY2023Q3 | pnht |
Accounts Receivable Diverted Current
AccountsReceivableDivertedCurrent
|
8333 | usd |
CY2022Q3 | pnht |
Accounts Receivable Diverted Current
AccountsReceivableDivertedCurrent
|
8332 | usd |
CY2023 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
94629 | usd |
CY2022 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
38214 | usd |